Greedy Trial Lawyer
FDA's Speedy Response To Avandia Heart Risk
Category: Right On!
The Food and Drug Administration has set a new record in its rapid response to the cardiac risks of the drug, Avandia.
Gooznews.com headlines the story of your FDA in action: FDA Told To Act on Avandia Five Years Ago
Safety analysts at the Food and Drug Administration told the top brass five years ago that thiazolidinediones like GlaxoSmithKline's Avandia (rosiglitazone) posed a heart attack risk to diabetics. Public Citizen released the internal memo today.
Other federal agencies and departments are studying the internal processes of the FDA in order to apply them to their work. FEMA is especially interested in reducing its response time to hurricanes and other disasters.
Trackback Pings
TrackBack URL for this entry:
http://www.greedytriallawyer.com/admin/mt-tb.cgi/503